Printer Friendly

Insmed to Present at Wells Fargo Securities Healthcare Conference; Presentation to Be Webcast Live.

Business Editors/Health/Medical Writers


Wells Fargo Securities Healthcare Conference

RICHMOND, Va.--(BUSINESS WIRE)--March 23, 2004

Insmed Incorporated (Nasdaq: INSM) announced today that Geoffrey Allan, Ph.D., President and Chief Executive Officer of Insmed, will present this Wednesday, March 24, 2004 at 3:15p.m. Eastern Time during the Wells Fargo Securities Healthcare Conference. The conference will take place at the St. Regis Hotel in New York, NY.

The presentation will be webcast live, and a recording will be made available following the presentation. The webcast and recording will be available on Insmed's corporate website, To access the webcast, please log on to Insmed's website approximately ten minutes prior to the presentation to register and download any necessary audio or visual software.

About Insmed

Insmed Incorporated is a biopharmaceutical company focused on the development of drug candidates for the treatment of metabolic diseases with unmet medical needs. Insmed's most advanced product, rhIGF-I/rhIGFBP-3, is currently in a pivotal Phase III clinical trial for the treatment of Growth Hormone Insensitivity Syndrome (GHIS). For further information about Insmed and rhIGF-I/rhIGFBP-3, please visit the company's corporate website at

Statements included within this press release, which are not historical in nature, may constitute forward-looking statements for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements regarding expected financial position, results of operations, cash flows, dividends, financing plans, business strategies, operating efficiencies or synergies, budgets, capital and other expenditures, competitive positions, growth opportunities for existing or proposed products or services, plans and objectives of management, demand for new pharmaceutical products, market trends in the pharmaceutical business, inflation and various economic and business trends. Such forward-looking statements are subject to numerous risks and uncertainties, including risks that product candidates may fail in the clinic or may not be successfully marketed, the company may lack financial resources to complete development of product candidates, competing products may be more successful, demand for new pharmaceutical products may decrease, the biopharmaceutical industry may experience negative market trends and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission. As a result of these and other risks and uncertainties, actual results may differ materially from those described in this press release.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Mar 23, 2004
Previous Article:Calix Maintains #1 Spot in Hot BLC Market; Over 110 US ILECs Deploying the Calix C7 in Ultra-Broadband Loop Carrier Applications.
Next Article:Renaissance Services Partners with Telelogic as Preferred Channel Partner for Aerospace and Defense Industry PLM Solution.

Related Articles
Insmed Incorporated Announces Access Information for Presentation At Prudential Vector Healthcare Conference.
Insmed Incorporated Announces Access Information for Presentation At Banc of America Healthcare 2001 Conference.
Insmed Selected to Present to BIO 2003 Business Forum; Presentation to be Webcast Live.
Insmed to Present to Rodman and Renshaw Healthcare Conference; Presentation to be Webcast Live.
Insmed to Present at Rodman and Renshaw Healthcare Conference May 13, 2004; Presentation to Be Webcast Live.
Insmed to Present at Rodman and Renshaw Healthcare Conference October 28, 2004; Presentation to Be Webcast Live.
Insmed to Present at the BIO Investor Forum Conference.
Insmed to Present at the Rodman and Renshaw 7th Annual Healthcare Conference.
Insmed to Present at the Lazard Capital Markets Life Sciences Conference.
Insmed to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters